Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

被引：0
|
作者：
Garcia Vega, D. [1 ]
Cinza-Sanjurjo, S. [2 ]
Eiras, S. [3 ,4 ]
Gonzalez-Juanatey, J. R. [1 ]
机构：
[1] Univ Hosp Santiago de Compostela, Santiago De Compostela, Spain
[2] Ctr Salud Milladoiro, Area Sanitaria Santiago de Compostela, Santiago De Compostela, Spain
[3] Hlth Res Inst Santiago de Compostela, Santiago De Compostela, Spain
[4] CIBERCV, Santiago De Compostela, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 591
页数：1
相关论文
共 50 条
  • [1] Combined sodium-glucose-transporters inhibitors (SGLT2i) and glucagon-like-peptide receptor agonist (GLP1ra) compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Vega, D. Garcia
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] Combined sodium-glucose-transporters inhibitors (SGLT2i) and glucagon-like-peptide receptor agonist (GLP1ra) compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Vega, D. Garcia
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [3] GLP1RA Compared to SGLT2i Improves Depression Parameters in Veterans
    Jain, Arad
    Ubalde, Shannen Nicole
    Esper, Layal
    Powell, Joseph
    Meyer, Kristin
    Sen, Sabyasachi
    OBESITY, 2023, 31 : 87 - 88
  • [4] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136
  • [5] Trends in GLP1RA and SGLT2i Use in Ischemic Stroke Patients With Diabetes
    Yanus, Matthew R.
    Saleni, Angela
    Bhavsar, Riya
    Zhang, Tony
    McCane, Charles D.
    Pan, Alan P.
    Vahidy, Farhaan
    Gadhia, Rajan R.
    STROKE, 2024, 55
  • [6] SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation
    Lopes, Antonio Cabral
    Lourenco, Olga
    Morgado, Manuel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (11) : 1081 - 1088
  • [7] Prevalence of SGLT2i and GLP1RA Use among US Adults with Type 2 Diabetes
    Limonte, Christine
    Hall, Yoshio
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    De Boer, Ian
    Zelnick, Leila
    DIABETES, 2022, 71
  • [8] Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
    Limonte, Christine P.
    Hall, Yoshio N.
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    de Boer, Ian H.
    Zelnick, Leila R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (06)
  • [9] RESULTS FROM THE NATIONWIDE FRENCH GLUCOSE (GLP1RA AND SGLT2I USE BY CARDIOLOGISTS SURVEY)
    Sabouret, P.
    Santos, R.
    Sharareh, A.
    Cohen, S.
    Ouazana, L.
    Guedj-Meynier, D.
    Garban, T.
    Rosencher, J.
    Adjedj, J.
    Dib, J. C.
    Khanoyan, P.
    Galli, M.
    Tokgozoglu, L.
    Biondi-Zoccai, G.
    Banach, M.
    Lellouche, N.
    Dievart, F.
    ATHEROSCLEROSIS, 2023, 379 : S196 - S197
  • [10] Outcomes of Heart Failure with Preserved Ejection Fraction with GLP1RA plus SGLT2i vs SGLT2i alone: A Propensity-Matched Nationwide Cohort Study
    Almas, Talal
    Al-Kindi, Sadeer
    Akbar, Absam
    Qureshi, Amal
    Perez, Jaime Abraham
    Harper, Elleson Grace
    Syed, Saif
    Alazazzi, Hosam
    Sullivan, Claire
    Neeland, Ian
    Deshmukh, Abhishek
    Anavekar, Nandan
    CIRCULATION, 2024, 150
12345